JPMorgan Diversified Return International Eqty ETF vs UnitedHealth Group Inc — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $73.74, while UnitedHealth Group Inc trades at $436.35 (market cap $382.83B). The key difference: UnitedHealth Group Inc pays a 2.2% dividend while JPMorgan Diversified Return International Eqty ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, JPMorgan Diversified Return International Eqty ETF nearer its low. Which is the better fit depends on your goals.
| JPIN | UNH | |
|---|---|---|
52-Week High | $76.96 | $431.68 |
52-Week Low | $63.14 | $237.77 |
Market Cap | — | $382.83B |
Sector | — | Health |
Enterprise Value | — | $429.52B |
Dividend Yield | — | 2.2% |
Signals from Pluang's Aura AI — not financial advice
JPIN, the JPMorgan Diversified Return International Equity ETF, trades at $73.11, down 0.5% on the day. Technical indicators show a bullish trend with strong moving average support, while oscillators are neutral. The ETF provides broad exposure to international large-cap value stocks, utilizing a smart-beta strategy for diversification. A dividend of $0.91 is scheduled for payment on June 25, 2026.
The ETF's outlook is supported by its diversified international equity approach, though it faces risks from global market volatility and currency fluctuations. Key resistance is at $74, with support at $73. The bullish technical setup suggests potential for near-term gains, but investors should weigh the inherent risks of international investing.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →